Open Access
| Issue |
SHS Web Conf.
Volume 208, 2024
2024 International Workshop on Digital Strategic Management (DSM 2024)
|
|
|---|---|---|
| Article Number | 04005 | |
| Number of page(s) | 9 | |
| Section | Chapter 4: Digital Management Case Studies | |
| DOI | https://doi.org/10.1051/shsconf/202420804005 | |
| Published online | 12 December 2024 | |
- Dosi, G., Marengo, L., Staccioli, J., & Virgillito, M. E. Big Pharma and monopoly capitalism: A long-term view. Structural Change and Economic Dynamics, 65, 15-35 (2023). [CrossRef] [Google Scholar]
- Flynn, M. B., & Silva, E. O. Framing access to medicines during COVID-19: A qualitative content analysis of Gilead’s Remdesivir. Global Public Health, 16(8-9), 1499-1511 (2021). [CrossRef] [Google Scholar]
- Pogge, T. Pharmaceutical patents and economic inequality. Health and Human Rights Journal, 25(2), 199-204 (2023). [Google Scholar]
- A. Ravn. Denver Journal of International Law and Policy. (n.d.). Patent policy: Balancing incentives and global accessibility, 2023.11.2, 2024.8.17, Retrieved from https://djilp.org/patent-policy-balancing-incentives-and-global-accessibility/ [Google Scholar]
- Robins Kaplan LLP. (2014). Gilead Sciences, Inc. v. Natco Pharma Ltd. Retrieved from https://www.robinskaplan.com/resources/legal-updates/generically-speaking-hatch-waxman-bulletin/2014/generically-speaking-summer-2014/gilead-sciences-inc-v-natco-pharma-ltd-fed-cir [Google Scholar]
- JD Supra. (2020). Gilead Sciences: A lesson in how legal tactics can extend the monopoly on a blockbuster drug, 2024, Summer, 2024.8.17, Retrieved from https://www.jdsupra.com/legalnews/gilead-sciences-a-lesson-in-how-legal-93408/ [Google Scholar]
- Lazonick, W., Hopkins, M., Jacobson, K., Sakinç, M. E., & Tulum, Ö. US pharma’s financialized business model. Institute for New Economic Thinking Working Paper Series, (60) (2017). [Google Scholar]
- Harvard Journal of Law & Technology. US v. Gilead: The US government flexes its patent muscles to fight high drug costs (2020). [Google Scholar]
- Xiao, R. Conflict and balance between intellectual property protection of pharmaceuticals and public health. Reports in Clinical Studies and Medicine, 4(1), 22-26 (2022). [Google Scholar]
- Visanko, H. H. E. Pharmaceutical patent monopolies’ effect on access and availability of medicines: Problems and solutions (Master’s thesis, Tilburg University) (2016). [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.